Literature DB >> 33530371

Viral Evasion of RIG-I-Like Receptor-Mediated Immunity through Dysregulation of Ubiquitination and ISGylation.

Cindy Chiang1, Guanqun Liu1, Michaela U Gack1.   

Abstract

Viral dysregulation or suppression of innate immune responses is a key determinant of virus-induced pathogenesis. Important sensors for the detection of virus infection are the RIG-I-like receptors (RLRs), which, in turn, are antagonized by many RNA viruses and DNA viruses. Among the different escape strategies are viral mechanisms to dysregulate the post-translational modifications (PTMs) that play pivotal roles in RLR regulation. In this review, we present the current knowledge of immune evasion by viral pathogens that manipulate ubiquitin- or ISG15-dependent mechanisms of RLR activation. Key viral strategies to evade RLR signaling include direct targeting of ubiquitin E3 ligases, active deubiquitination using viral deubiquitinating enzymes (DUBs), and the upregulation of cellular DUBs that regulate RLR signaling. Additionally, we summarize emerging new evidence that shows that enzymes of certain coronaviruses such as SARS-CoV-2, the causative agent of the current COVID-19 pandemic, actively deISGylate key molecules in the RLR pathway to escape type I interferon (IFN)-mediated antiviral responses. Finally, we discuss the possibility of targeting virally-encoded proteins that manipulate ubiquitin- or ISG15-mediated innate immune responses for the development of new antivirals and vaccines.

Entities:  

Keywords:  ISG15; innate immunity; interferon; ubiquitin; viral evasion

Mesh:

Substances:

Year:  2021        PMID: 33530371      PMCID: PMC7910861          DOI: 10.3390/v13020182

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  92 in total

1.  UBP43 (USP18) specifically removes ISG15 from conjugated proteins.

Authors:  Michael P Malakhov; Oxana A Malakhova; Keun Il Kim; Kenneth J Ritchie; Dong-Er Zhang
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

2.  Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection.

Authors:  Kenneth J Ritchie; Chang S Hahn; Keun Il Kim; Ming Yan; Dabralee Rosario; Li Li; Juan Carlos de la Torre; Dong-Er Zhang
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

3.  Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Authors:  Yueh-Ming Loo; Jamie Fornek; Nanette Crochet; Gagan Bajwa; Olivia Perwitasari; Luis Martinez-Sobrido; Shizuo Akira; Michelle A Gill; Adolfo García-Sastre; Michael G Katze; Michael Gale
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

4.  Amino acid requirements for MDA5 and LGP2 recognition by paramyxovirus V proteins: a single arginine distinguishes MDA5 from RIG-I.

Authors:  Kenny R Rodriguez; Curt M Horvath
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

5.  TRIM65-catalized ubiquitination is essential for MDA5-mediated antiviral innate immunity.

Authors:  Xueting Lang; Tiantian Tang; Tengchuan Jin; Chen Ding; Rongbin Zhou; Wei Jiang
Journal:  J Exp Med       Date:  2016-12-28       Impact factor: 14.307

Review 6.  TRIM Proteins in Host Defense and Viral Pathogenesis.

Authors:  Maria I Giraldo; Adam Hage; Sarah van Tol; Ricardo Rajsbaum
Journal:  Curr Clin Microbiol Rep       Date:  2020-08-08

7.  Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling.

Authors:  Junsu Ban; Na-Rae Lee; Noh-Jin Lee; Jong Kil Lee; Fu-Shi Quan; Kyung-Soo Inn
Journal:  Viruses       Date:  2018-12-14       Impact factor: 5.048

8.  MiR-202-5p Inhibits RIG-I-Dependent Innate Immune Responses to RGNNV Infection by Targeting TRIM25 to Mediate RIG-I Ubiquitination.

Authors:  Wei Liu; Yilin Jin; Wanwan Zhang; Yangxi Xiang; Peng Jia; Meisheng Yi; Kuntong Jia
Journal:  Viruses       Date:  2020-02-27       Impact factor: 5.048

9.  Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay.

Authors:  Eleni Pitsillou; Julia Liang; Chris Karagiannis; Katherine Ververis; Kevion K Darmawan; Ken Ng; Andrew Hung; Tom C Karagiannis
Journal:  Comput Biol Chem       Date:  2020-10-23       Impact factor: 2.877

10.  Regulation of Retinoic Acid Inducible Gene-I (RIG-I) Activation by the Histone Deacetylase 6.

Authors:  Helene Minyi Liu; Fuguo Jiang; Yueh Ming Loo; ShuZhen Hsu; Tien-Ying Hsiang; Joseph Marcotrigiano; Michael Gale
Journal:  EBioMedicine       Date:  2016-06-11       Impact factor: 8.143

View more
  6 in total

Review 1.  Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15).

Authors:  Inbar Magid Gold; Noa Reis; Fabian Glaser; Michael H Glickman
Journal:  Semin Cell Dev Biol       Date:  2022-06-25       Impact factor: 7.499

Review 2.  The Roles of Ubiquitination in Pathogenesis of Influenza Virus Infection.

Authors:  Eun-Sook Park; Mehrangiz Dezhbord; Ah Ram Lee; Kyun-Hwan Kim
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

Review 3.  ISG15 and ISGylation in Human Diseases.

Authors:  Oygul Mirzalieva; Meredith Juncker; Joshua Schwartzenburg; Shyamal Desai
Journal:  Cells       Date:  2022-02-04       Impact factor: 7.666

Review 4.  The Regulatory Network of Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Pathway in Viral Evasion.

Authors:  Tongyu Hu; Mingyu Pan; Yue Yin; Chen Wang; Ye Cui; Quanyi Wang
Journal:  Front Microbiol       Date:  2021-12-13       Impact factor: 5.640

5.  Transcriptome Analysis of Retinoic Acid-Inducible Gene I Overexpression Reveals the Potential Genes for Autophagy-Related Negative Regulation.

Authors:  Shaotang Ye; Chen Tan; Xiaoyun Yang; Ji Wang; Qi Li; Liang Xu; Zhen Wang; Jianwei Mao; Jingyu Wang; Kui Cheng; Aolei Chen; Pei Zhou; Shoujun Li
Journal:  Cells       Date:  2022-06-23       Impact factor: 7.666

Review 6.  HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response.

Authors:  Nicholas A Mathieu; Ermela Paparisto; Stephen D Barr; Donald E Spratt
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.